The App       Resources       Trainings       More info

The app

Free to download, AlcoPath features gold standard diagnostic tests and suggested treatment advice that is easy to add to clinical records.

STEP ONE:

Select an assessment from the home screen to begin.

STEP TWO:

Answer the questions with a tap of your finger.

STEP THREE:

Instant results that you can print or email direct from the app.

WEKP COGNITIVE ASSESSMENT

AlcoPath's cognitive assessment incorporates:

  • Six Item Cognitive Impairment Test (6CIT)
  • Ataxia test
  • Opthalmoplegia test
  • Associated risk factors

 

This assessment tool aids the diagnosis of Wernicke's encephalopathy.  The BNF outlines the treatment for this condition which is straight-forward once symptoms are detected.

 

If patients aren’t treated for Wernicke’s Encepathlopathy promptly the risks are great, including:

  • Progression to Korsakoff’s Psychosis in 85% of cases
    (a condition characterised by ongoing cognitive impairment)
  • Long term instituationalisation in 25% of cases
  • Death in 20% of cases (Victor, Adams & Collins, 1989)

 

It is these risks of progression of the condition of Wernicke’s Encepathlopathy being left undiagnosed and untreated that were the rationale for the creation of AlcoPath.

 

THE VALIDATED TEST ELEMENT

A key element of the cognitive assessment is the validated test 6CIT (Brooke & Bullock, 1999). This makes AlcoPath’s WEKP Cognitive Assessment Tool ideally suited to those suspected of having Wernicke-Korsakoff’s syndrome. It gives a score which if 8 or above is considered positive for an impairment.

 

AlcoPath will automatically calculate the score for 6CIT as you progress through the test and give you advice on treatment at the end.

 

 

WITHDRAWAL ASSESSMENT

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) scale has ten items which add up to indicate the current severity of a patient’s alcohol withdrawal. CIWA-Ar was refined from earlier validated alcohol withdrawal tools and is considered to have good inter-rater reliability (Sullivan, Sykora, Schneiderman, Naranjo & Sellers, 1989). CIWA-Ar informs treatment of the symptoms, when other factors (prompted by AlcoPath) are considered.

 

The use of a withdrawal assessment tool like CIWA-Ar in AlcoPath is associated with:

  • Reducing hospital days for treatment
  • Lower overall doses of medication
    (Saitz, Mayo-Smith, & Roberts, 1994).

 

THE TEST

Each item on the scale is scored independently, and the summation of the scores yields an aggregate value that correlates to the severity of alcohol withdrawal, with ranges of scores designed to prompt specific management decisions such as the administration of benzodiazepines. The ten items evaluated on the scale are common symptoms and signs of alcohol withdrawal, and are as follows:

  • Nausea and vomiting
  • Tremor
  • Paroxysmal sweats
  • Anxiety
  • Agitation
  • Tactile disturbances
  • Auditory disturbances
  • Visual disturbances
  • Headache
  • Orientation and clouded sensorium

 

AlcoPath will automatically calculate the CIWA-Ar score as you progress through the test and give you advice on treatment at the end.

 

The assessments

PATIENT RECORDS

QUICKLY AND EASILY UPDATE CLINICAL RECORDS

Tap the share icon on the results screen to print or email a detailed pdf of the assessment and results.

 

EXAMPLE OF RESULTS PDF

 

WEKP COGNITIVE ASSESSMENT

Incorporating the Six Item Cognitive Impairment Test (6CIT), the AlcoPath assessment tool aids the diagnosis of those with suspected Wernicke's encephalopathy. Treatment of this condition is simple, but, undiagnosed it leads to death in up to 20% of cases, or to Korsakoff's syndrome in 85% of survivors. Up to 25% of the Korsakoff group will require long-term institutionalisation.

 

THE TEST

6CIT is a validated (Brooke & Bullock, 1999) cognitive assessment ideally suited to those suspected of having confusion/memory problems thought to be attributed to Wernicke-Korsakoff’s syndrome. It gives a score which if 8 or above is considered positive for an impairment.

 

AlcoPath will automatically calculate the score for 6CIT as you progress through the test and give you advice on treatment at the end.

 

WITHDRAWAL ASSESSMENT

The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar), is a validated, ten item test providing efficient and objective assessment and management of alcohol withdrawal. A randomized, double blind trial published in JAMA in 1994 showed that management for alcohol withdrawal that was guided by the CiWA-Ar scale resulted in decreased treatment duration and total use of benzodiazepines.

 

THE TEST

Each item on the scale is scored independently, and the summation of the scores yields an aggregate value that correlates to the severity of alcohol withdrawal, with ranges of scores designed to prompt specific management decisions such as the administration of benzodiazepines. The ten items evaluated on the scale are common symptoms and signs of alcohol withdrawal, and are as follows:

Nausea and vomiting

Tremor

Paroxysmal sweats

Anxiety

Agitation

Tactile disturbances

Auditory disturbances

Visual disturbances

Headache

Orientation and clouded sensorium

 

AlcoPath will automatically calculate the CIWA-Ar score as you progress through the test and give you advice on treatment at the end.

The app

Free to download, AlcoPath features gold standard diagnostic tests and recommended treatment advice that is easy to add to your patient's records.

The

assessments

YOUR RECORDS